class="info-alert">『Your web browser does not support JavaScript, but it does not affect browsing through the rest of the web site.』
jump to main content

Industrial Technology Research Institute

:::

Automatic Cell Production System

Technology Overview

ITRI's Automatic Cell Production System is Taiwan's first module designd for large-scale cell production.
ITRI's Automatic Cell Production System is Taiwan's first module designd for large-scale cell production.

Regenerative medicine and cell therapies are at the forefront of medical innovation. Chronic diseases such as cardiovascular disease, neuropathy, and diabetes can see outstanding therapeutic results through the regeneration and repair of transplant cells. However, current cell cultivation technologies are expensive and struggle to produce large quantities of high-quality cells effieciently.

ITRI's Automatic Cell Production System is Taiwan's first module designd for large-scale cell production. This system addresses these challenges by efficiently producing large quantities of high-quality cells. Cells are cultivated in a highly conductive medium to ensure quality and stable expansion. The cell growth environment is continuously monitored in real-time, tracking cell numbers, cell morphology, and contamination levels. The system features an automated solution exchange procedure, minimizing the risk of contamination from manual intervention and reducing labor costs by up to 50%. It also allows cells to be expanded over 1,000 times, supporting continuous cell generation.

The quantity and quality of cells produced by ITRI Automatic Cell Production System fulfill clinical needs, positioning this groundbreaking technology as a key advancement for future cell therapy applications.

  • Features
    • Automatic CO2 regulated cell incubator
    • Automatic cell subculture and harvesting
    • Artificial intelligence cell imaging
    • Programmed cell medium exchange
  • Specifications
    • Simultaneously transporting and positioning 36 groups of T75 flask/T150 flask/HYPER flask
    • Cell counting, contamination detection, images recording and monitoring
    • Medium is exchanged automatically based on scheduling

Applications & Benefits

  • Cell banking/storage
  • Tissue engineering for regeneration
  • Quality control of cell product
  • Cell therapy

Contact

Dr. Kuo-Kuei Huang
light@itri.org.tw

The system features an automated solution exchange procedure, minimizing the risk of contamination from manual intervention and reducing labor costs by up to 50%.
The system features an automated solution exchange procedure, minimizing the risk of contamination from manual intervention and reducing labor costs by up to 50%.

ITRI has already completed system integration and operational tests, aiming to improve the quality and capacity of large-scale cell culture while lowering the production cost with intelligent monitoring.

One-Stop Biomedical Services


One-Stop Biomedical Services

  • Listing Regulations Consulting: FDA/TFDA/CE application, medical device verification/export, medical device/medicine registration, IRB document organization, clinical trial application, and more.
  • Technology Transfer: Bio-IT, diagnostics and precision medicine technology, regeneration medicine technology, natural medicine and healthcare technology, targeted drug and delivery technology.
  • Model Translation: Domestic supply chain linkage, medical device design control, market analysis, strategy analysis of regulation in commercialization, and more.
  • Preclinical/Clinical Trial: Functional safety assessments, clinical research organization linkage, clinical evaluation and analysis, clinical trial planning, clinical trial analysis and reports.
  • Other Services: Quality system consulting, commercialization consulting, smart health solutions, software validation, medical device risk management, information security risk evaluation, technical documents preparation, business ecosystem linkage, and more.